Table 2 Urinary excretion of glycation, oxidation and nitration free adducts (nmol/mg creatinine).
Urinary free adduct | Normoalbuminuria (n = 30) | Microalbuminuria (n = 55) | P value NA vs. MA* | P value NA and stable GFR vs. early GFR decline* | |
|---|---|---|---|---|---|
Stable GFR (n = 33) | Early GFR decline (n = 22) | ||||
FL | 32.0 [22.3–42.3] | 37.5 [13.5–71.7] | 60.6 [30.9–99.4] | ||
CML | 3.30 [2.33–4.70] | 2.63 [1.11–5.94] | 4.04 [2.87–8.45] | ||
CEL | 1.22 [0.90–1.61] | 1.06 [0.42–2.53] | 1.80 [1.18–3.29] | ||
G-H1 | 1.92 [1.29–2.39] | 1.42 [0.42–2.99] | 1.78 [1.33–2.64] | ||
MG-H1 | 61.9 [30.4–92.3] | 42.7 [13.0–93.1] | 51.9 [29.2–155.3] | ||
3DG-H | 1.34 [1.04–1.94] | 0.80 [0.39–1.65] | 1.42 [0.74–1.95] | ||
CMA | 1.61 [1.25–2.24] | 1.70 [0.66–3.66] | 2.04 [1.36–4.03] | ||
GOLD | 0.0126 [0.0092–0.0207] | 0.0189 [0.0057–0.0243] | 0.0204 [0.0101–0.0249] | ||
MOLD | 0.069 [0.050–0.107] | 0.097 [0.065–0.139] | 0.109 [0.076–0.158] | ||
Pentosidine | 0.0102 [0.0064–0.0170] | 0.0313 [0.0144–0.0905] | 0.0561 [0.0273–0.1027] | < 0.0001 | < 0.01 |
MetSO | 1.12 [0.56–1.93] | 0.83 [0.44–1.64] | 0.60 [0.30–1.20] | ||
DT | 0.0529 [0.0404–0.0639] | 0.0325 [0.0175–0.1036] | 0.0547 [0.0392–0.0950] | ||
NFK | 0.285 [0.205–0.352] | 0.138 [0.042–0.320] | 0.189 [0.077–0.282] | ||
3-NT | 0.0094 [0.0041–0.0169] | 0.0136 [0.0045–0.0301] | 0.0117 [0.0050–0.0369] | ||